# Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer

> **NCT02960061** · PHASE3 · UNKNOWN · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 640 (estimated)

## Conditions studied

- Survival

## Interventions

- **DRUG:** Neoadjuvant chemotherapy
- **PROCEDURE:** D2 radical resection
- **DRUG:** Hyperthermic intraperitoneal perfusion chemotherapy
- **DRUG:** Adjuvant chemotherapy

## Key facts

- **NCT ID:** NCT02960061
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 640 (ESTIMATED)
- **Last updated:** 2016-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960061, "Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02960061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*